History and introduction of dendrimers
暂无分享,去创建一个
Prashant Kesharwani | Bapi Gorain | Hira Choudhury | Sreenivas Patro Sisinthy | P. Kesharwani | H. Choudhury | B. Gorain
[1] P. Sengupta,et al. Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges. , 2019, International journal of pharmaceutics.
[2] J. Reymond,et al. Peptide dendrimers as artificial enzymes, receptors, and drug-delivery agents. , 2006, Accounts of chemical research.
[3] P. Kesharwani,et al. Recent advances in folic acid engineered nanocarriers for treatment of breast cancer , 2020 .
[4] C. Hawker,et al. Unimolecular micelles and globular amphiphiles: dendritic macromolecules as novel recyclable solubilization agents , 1993 .
[5] M. Hawthorne,et al. Dendritic closomers: novel spherical hybrid dendrimers. , 2013, Chemical communications.
[6] V. Percec,et al. Rational Design of the First Nonspherical Dendrimer Which Displays Calamitic Nematic and Smectic Thermotropic Liquid Crystalline Phases , 1995 .
[7] J. Tam,et al. Synthesis of Peptide Dendrimer , 1994 .
[8] Manisha Pandey,et al. Dendrimers as Effective Carriers for the Treatment of Brain Tumor , 2018 .
[9] P. Mehta,et al. Dendrimers for pulmonary delivery: current perspectives and future challenges , 2019, New Journal of Chemistry.
[10] Anil K Patri,et al. Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.
[11] P. Kesharwani,et al. GENERATION DEPENDENT TARGETING POTENTIAL OF DONEPEZIL LOADED POLY (PROPYLENEIMINE) DENDRIMER THROUGH GOAT NASAL MUCOSA , 2018, International Journal of Pharmacy and Pharmaceutical Sciences.
[12] J Fraser Stoddart,et al. Design and synthesis of glycodendrimers. , 2002, Journal of biotechnology.
[13] T. Tsumuraya,et al. General strategy for the systematic synthesis of oligosiloxanes. Silicone dendrimers , 1990 .
[14] P. Kesharwani,et al. The potential of dendrimer in delivery of therapeutics for dentistry , 2019, Heliyon.
[15] Walter H Backes,et al. Evaluation of Gd(III)DTPA‐terminated poly(propylene imine) dendrimers as contrast agents for MR imaging , 2006, NMR in biomedicine.
[16] V. Mishra,et al. Dendrimer technologies for brain tumor. , 2016, Drug discovery today.
[17] P. Kesharwani,et al. Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers , 2015, Drug development and industrial pharmacy.
[18] R. Mülhaupt,et al. Dendritic polyols based on carbosilanes ‐ lipophilic dendrimers with hydrophilic skin , 1996 .
[19] N. K. Jain,et al. Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector. , 2014, Nanomedicine.
[20] Umesh Gupta,et al. Dendrimers as an Effective Nanocarrier in Cardiovascular Disease. , 2015, Current pharmaceutical design.
[21] Fengli Gao,et al. Folic acid-modified diatrizoic acid-linked dendrimer-entrapped gold nanoparticles enable targeted CT imaging of human cervical cancer , 2018, Journal of Cancer.
[22] R. Tekade,et al. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. , 2017, Drug discovery today.
[23] M. Tempero,et al. A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer , 2013, British Journal of Cancer.
[24] Nathalie Launay,et al. A General Synthetic Strategy for Neutral Phosphorus‐Containing Dendrimers , 1994 .
[25] N. K. Jain,et al. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer. , 2014, Biomaterials.
[26] M A Fischl,et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] M. Malkoch,et al. CHAPTER 1. Introduction to Dendrimers and Other Dendritic Polymers , 2020 .
[28] Morteza Milani,et al. Dendrimers: synthesis, applications, and properties , 2014, Nanoscale Research Letters.
[29] Jeffrey S. Moore,et al. Rapid Construction of Large‐size Phenylacetylene Dendrimers up to 12.5 Nanometers in Molecular Diameter , 1993 .
[30] E. W. Meijer,et al. Synthesis and Characterization of a Chiral Dendrimer Derived from Pentaerythritol , 1994 .
[31] George R. Newkome,et al. Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol , 1985 .
[32] D. Luo,et al. Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery , 2002 .
[33] Nancy E. Magaña-Vergara,et al. In vitro activity of steroidal dendrimers on Trypanosoma cruzi epimastigote form with PAMAM dendrons modified by "click" chemistry. , 2019, Bioorganic chemistry.
[34] R. Tekade,et al. The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers , 2013, Journal of Nanoparticle Research.
[35] J. Fréchet,et al. Discovery of dendrimers and dendritic polymers: A brief historical perspective* , 2002 .
[36] P. Kesharwani,et al. Conclusion and Future Prospective of Polymeric Nanoparticles for Cancer Therapy , 2019, Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics.
[37] P. Ellis,et al. Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Claudia Sandoval-Yáñez,et al. Dendrimers: Amazing Platforms for Bioactive Molecule Delivery Systems , 2020, Materials.
[39] David R. Liu,et al. Sequence-Controlled Polymers , 2013, Science.
[40] N. K. Jain,et al. Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[41] P. Kesharwani,et al. Dendrimer toxicity: Let's meet the challenge. , 2010, International journal of pharmaceutics.
[42] C. Hawker,et al. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .
[43] Viney Lather,et al. Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues , 2014, Journal of pharmacy & bioallied sciences.
[44] B. Nanjwade,et al. Dendrimers: emerging polymers for drug-delivery systems. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[45] F. Sarkar,et al. Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures. , 2016, Journal of colloid and interface science.
[46] P. Kesharwani,et al. Synthesis, characterization and in vitro assessment of colloidal gold nanoparticles of Gemcitabine with natural polysaccharides for treatment of breast cancer , 2020 .
[47] Yuanjie Liu,et al. Dual-functionalized PAMAM dendrimers with improved P-glycoprotein inhibition and tight junction modulating effect. , 2013, Biomacromolecules.
[48] Sanjeev Banerjee,et al. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. , 2015, Colloids and surfaces. B, Biointerfaces.
[49] M. Cloninger,et al. Mannose functionalization of a sixth generation dendrimer. , 2001, Biomacromolecules.
[50] N. K. Jain,et al. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[51] Muktika Tekade,et al. The use of nanoscaffolds and dendrimers in tissue engineering. , 2017, Drug discovery today.
[52] Sheo Datta Maurya,et al. POTENTIAL APPLICATION OF DENDRIMERS IN DRUG DELIVERY: A CONCISE REVIEW AND UPDATE , 2016 .
[53] Prashant Kesharwani,et al. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. , 2015, Drug discovery today.
[54] T. Xu,et al. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. , 2008, Frontiers in bioscience : a journal and virtual library.
[55] Jong-sang Park,et al. Synthesis of a Barbell-like Triblock Copolymer, Poly(l-lysine) Dendrimer-block-Poly(ethylene glycol)-block-Poly(l-lysine) Dendrimer, and Its Self-Assembly with Plasmid DNA , 2000 .
[56] Manisha Pandey,et al. Nose to brain delivery of nanocarriers towards attenuation of demented condition. , 2020, Current pharmaceutical design.
[57] S Sridevi,et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[58] N. K. Jain,et al. A review on comparative study of PPI and PAMAM dendrimers , 2016, Journal of Nanoparticle Research.
[59] J. F. Stoddart,et al. Synthesis of Carbohydrate-Containing Dendrimers. 5. Preparation of Dendrimers Using Unprotected Carbohydrates , 1997 .
[60] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[61] Francis C Szoka,et al. Designing dendrimers for biological applications , 2005, Nature Biotechnology.
[62] Ryan M. Pearson,et al. Dendron‐Based Micelles for Topical Delivery of Endoxifen: A Potential Chemo‐Preventive Medicine for Breast Cancer , 2014 .
[63] Xue Li,et al. Stimuli-responsive polymers and their applications , 2017 .
[64] D. Tomalia,et al. CHARACTERIZATIONS OF CORE-SHELL TECTO-(DENDRIMER) MOLECULES BY TAPPING MODE ATOMIC FORCE MICROSCOPY , 1999 .
[65] Martin W. Brechbiel,et al. Metal-chelate-dendrimer-antibody constructs for use in radioimmunotherapy and imaging , 1994 .
[66] Michael B. Hall,et al. Dendritic macromolecules: synthesis of starburst dendrimers , 1986 .
[67] J. Frolík,et al. Biocompatible Size-Defined Dendrimer-Albumin Binding Protein Hybrid Materials as a Versatile Platform for Biomedical Applications. , 2016, Macromolecular bioscience.
[68] N. K. Jain,et al. Mucoadhesion: A promising approach in drug delivery system , 2016 .
[69] P. Kesharwani,et al. In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles. , 2017, Journal of pharmaceutical sciences.
[70] Murray Goodman,et al. Collagen mimetic dendrimers. , 2002, Journal of the American Chemical Society.
[71] Paul J. Flory,et al. Molecular Size Distribution in Three Dimensional Polymers. I. Gelation1 , 1941 .
[72] Shuhua Bai,et al. Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. , 2007, Journal of pharmaceutical sciences.
[73] P. Kesharwani,et al. Entrapment of drug-sorbate complex in submicron emulsion: A potential approach to improve antimicrobial activity in bacterial corneal infection , 2019, Journal of Drug Delivery Science and Technology.
[74] N. K. Jain,et al. Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment. , 2016, Journal of colloid and interface science.
[75] R. Roy,et al. Glycodendrimers: novel glycotope isosteres unmasking sugar coding. case study with T-antigen markers from breast cancer MUC1 glycoprotein. , 2002, Journal of biotechnology.
[76] Michael Hawkins,et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[77] P. Kesharwani,et al. Current attempts to implement microRNA-based diagnostics and therapy in cardiovascular and metabolic disease: a promising future. , 2017, Drug discovery today.
[78] P. Sengupta,et al. Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route. , 2017, Current pharmaceutical design.
[79] P. Kesharwani,et al. Theranostic application of nanoemulsion in chemotherapy. , 2020, Drug discovery today.
[80] G. Mishra,et al. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer. , 2018, Current pharmaceutical design.
[81] N. K. Jain,et al. Generation dependent hemolytic profile of folate engineered poly(propyleneimine) dendrimer , 2015 .
[82] P. Kesharwani,et al. Dendrimer-Based Nanoparticulate Delivery System for Cancer Therapy , 2019, Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics.
[83] Michael Malkoch,et al. Simplifying the synthesis of dendrimers: accelerated approaches. , 2012, Chemical Society reviews.
[84] Sanjeev Banerjee,et al. PAMAM dendrimers as promising nanocarriers for RNAi therapeutics , 2015 .
[85] R. Tekade,et al. Impact of pegylation on biopharmaceutical properties of dendrimers , 2015 .
[86] P. Kesharwani,et al. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. , 2016, Acta biomaterialia.
[87] J. Tam,et al. Peptide dendrimers: applications and synthesis. , 2002, Journal of biotechnology.
[88] P. Kesharwani,et al. Investigation on Secondary Structure Alterations of Protein Drugs as an Indicator of Their Biological Activity Upon Thermal Exposure , 2019, The Protein Journal.
[89] J. Fréchet,et al. Synthesis and Surface Functionalization of Aliphatic Polyether Dendrons , 2000 .
[90] R. Roy,et al. Solid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin , 1993 .
[91] Keerti Jain,et al. Dendrimer as nanocarrier for drug delivery , 2014 .
[92] T. Xu,et al. Dendrimers as drug carriers: applications in different routes of drug administration. , 2008, Journal of pharmaceutical sciences.
[93] E. W. Meijer,et al. New Dendrimer–Peptide Host–Guest Complexes: Towards Dendrimers as Peptide Carriers , 2002, Chembiochem : a European journal of chemical biology.
[94] T. Vandamme,et al. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[95] V. Mishra,et al. Dendrimer-mediated approaches for the treatment of brain tumor , 2016, Journal of biomaterials science. Polymer edition.
[96] James R. Dewald,et al. A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .
[97] Z. Sideratou,et al. Solubilization and Release Properties of PEGylated Diaminobutane Poly(propylene imine) Dendrimers , 2001 .
[98] R. Mülhaupt,et al. A mesogen‐functionized carbosilane dendrimer: A dendritic liquid crystalline polymer , 1996 .
[99] A. Ray,et al. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin. , 2013, International journal of pharmaceutics.
[100] N. K. Jain,et al. Evaluation of dendrimer safety and efficacy through cell line studies. , 2011, Current drug targets.
[101] P. Kesharwani,et al. Curcumin loaded poly (amidoamine) dendrimer-plamitic acid core-shell nanoparticles as anti-stress therapeutics , 2020, Drug development and industrial pharmacy.
[102] J. Schellens,et al. Oral Delivery of Taxanes , 2001, Investigational New Drugs.
[103] M. Piccart,et al. A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC). , 2014 .
[104] N. K. Jain,et al. A review of nanocarriers for the delivery of small interfering RNA. , 2012, Biomaterials.
[105] D. Reinhoudt,et al. Controlled assembly of nanosized metallodendrimers , 1996 .
[106] Andrew C Larson,et al. Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer , 2013, International journal of nanomedicine.
[107] T. Pal,et al. A novel approach for nanoemulsion components screening and nanoemulsion assay of olmesartan medoxomil through a developed and validated HPLC method , 2013 .
[108] P. Kesharwani,et al. Polyvalent Folate-Dendrimer-Coated Iron Oxide Theranostic Nanoparticles for Simultaneous Magnetic Resonance Imaging and Precise Cancer Cell Targeting. , 2017, Biomacromolecules.
[109] Roberto Parise-Filho,et al. Dendrimers in the context of nanomedicine. , 2019, International journal of pharmaceutics.
[110] P. Kesharwani,et al. Dendrimer entrapped microsponge gel of dithranol for effective topical treatment , 2019, Heliyon.
[111] A. D'emanuele,et al. In vitro evaluation of dendrimer prodrugs for oral drug delivery. , 2007, International journal of pharmaceutics.
[112] C. Kokare,et al. Intranasal teriflunomide microemulsion: An improved chemotherapeutic approach in glioblastoma , 2019, Journal of Drug Delivery Science and Technology.
[113] E. Buhleier,et al. "Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies , 1978 .
[114] N. K. Jain,et al. Generation Dependent Safety and Efficacy of Folic Acid Conjugated Dendrimer Based Anticancer Drug Formulations , 2014, Pharmaceutical Research.
[115] T. P. Davis,et al. Understanding Effects of PAMAM Dendrimer Size and Surface Chemistry on Serum Protein Binding with Discrete Molecular Dynamics Simulations. , 2018, ACS sustainable chemistry & engineering.
[116] F. Alustiza,et al. Formation of dendrimer-guest complexes as a strategy to increase the solubility of a phenazine N, N′-dioxide derivative with antitumor activity , 2019, Heliyon.
[117] Ling Peng,et al. Poly(amidoamine) dendrimers: covalent and supramolecular synthesis , 2019, Materials Today Chemistry.
[118] Manisha Pandey,et al. Dendrimer-Based Nanocarriers in Lung Cancer Therapy , 2019, Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer.
[119] Neil B. McKeown,et al. Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity , 2003, Pharmaceutical Research.
[120] A. Salgado,et al. Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—A review , 2010 .
[121] Antony D'Emanuele,et al. The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[122] P C Lauterbur,et al. Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.
[123] D. Seebach,et al. A Simple Procedure for the Preparation of Chiral ‘Tris(hydroxymethyl)methane’ Derivatives , 1993 .
[124] N. K. Jain,et al. Dendrimer generational nomenclature: the need to harmonize. , 2015, Drug discovery today.
[125] K. Dua,et al. Recent Advances in Oncological Submissions of Dendrimer. , 2017, Current pharmaceutical design.
[126] Seungpyo Hong,et al. Dendrimer-based nanocarriers: a versatile platform for drug delivery. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[127] Manisha Pandey,et al. Nanotechnology based approaches for anti-diabetic drugs delivery. , 2018, Diabetes research and clinical practice.
[128] N. K. Jain,et al. One platform comparison of solubilization potential of dendrimer with some solubilizing agents , 2015, Drug development and industrial pharmacy.
[129] Donald A. Tomalia,et al. Dendrimers with Hydrophobic Cores and the Formation of Supramolecular Dendrimer−Surfactant Assemblies , 1997 .
[130] M. Morilla,et al. Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels , 2012, International journal of nanomedicine.
[131] Keerti Jain,et al. Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery. , 2017, Drug discovery today.
[132] Donald A Tomalia,et al. Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.
[133] Umesh Gupta,et al. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery. , 2017, Drug discovery today.
[134] Marta Sowinska,et al. Advances in the chemistry of dendrimers , 2014 .
[135] Neil M. Stainton,et al. A convergent synthesis of extended aryl ester dendrimers , 1994 .
[136] I. Vural,et al. In Vitro/In Vivo Evaluation of Dexamethasone--PAMAM Dendrimer Complexes for Retinal Drug Delivery. , 2015, Journal of pharmaceutical sciences.
[137] P. Kesharwani,et al. Dendrimers in Targeting and Delivery of Drugs , 2017 .
[138] P. Kesharwani,et al. Immune checkpoint inhibitors: a promising anticancer therapy. , 2019, Drug discovery today.
[139] D. Farin,et al. Surface Fractality of Dendrimers , 1991 .
[140] Omathanu Perumal,et al. Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. , 2008, International journal of pharmaceutics.
[141] F. Szoka,et al. Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. , 2002, Bioconjugate chemistry.
[142] Deborah S. Goldberg,et al. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[143] Manisha Pandey,et al. Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging , 2019, Progress in Materials Science.
[144] Keerti Jain,et al. A review of glycosylated carriers for drug delivery. , 2012, Biomaterials.
[145] Manisha Pandey,et al. Nanoemulsions as Effective Carriers for the Treatment of Lung Cancer , 2019, Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer.
[146] N. K. Jain,et al. Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy , 2008, Journal of drug targeting.